By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GTX Corp 

117 West 9th Street
Suite 1214
Los Angeles  California  90015  U.S.A.
Phone: 213-489-3019 Fax: 213-489-3062



Company News
GTX Corp Announces Webcast Of Corporate Presentation At The UBS Global Healthcare Conference 2015 5/12/2015 11:23:24 AM
GTX Corp Provides Corporate Update And Reports First Quarter 2015 Financial Results 5/8/2015 11:45:56 AM
GTX Corp And The University of Tennessee Research Foundation Enter Into Exclusive License Agreement To Develop UTRF’s SARD Drug Technology 4/23/2015 11:34:57 AM
GTX Corp Announces Webcast of Corporate Presentation at the Stifel 2014 Healthcare Conference 11/12/2014 9:59:09 AM
GTX Corp Provides Corporate Update And Reports Third Quarter 2014 Financial Results 11/10/2014 10:17:55 AM
GTX Corp's Phase III Clinical Studies of Enobosarm (GTx-024) to Continue as Planned Following Planned Safety Review 4/15/2013 12:17:42 PM
GTx, Inc. (GTXI)-758 Poster Presentation of Phase II Trial Data in Advanced Prostate Cancer Selected as One of the Best Posters at the 28th Annual European Association of Urology Congress 3/19/2013 9:41:32 AM
GTX Corp Release: Aetrex Navistar™ GPS SHOES for Tracking Alzheimer's Sufferers Now Available in the UK and Ireland 10/11/2012 11:28:37 AM
GTX Corp to Present Scientific Poster Presentations on Enobosarm to Prevent and Treat Muscle Wasting in Cancer Patients 10/8/2012 9:50:20 AM
GTX Corp Announces Presentation on the Ability of Capesaris® to Reduce Free Testosterone and Suppress PSA in Men With Castration Resistant Prostate Cancer 9/19/2012 8:49:19 AM